```html

Upper Gastrointestinal Bleed (UGIB): A Comprehensive Medical Guide

Overview

An upper gastrointestinal (GI) bleed refers to bleeding that originates proximal to the ligament of Treitz, which includes the esophagus, stomach, and duodenum. It is a medical emergency when massive or ongoing, but many cases are modest and can be managed conservatively. UGIB accounts for roughly 5–10% of all hospital admissions for GI problems and is responsible for an estimated 150,000–300,000 hospitalizations per year in the United States.

Both men and women can be affected, but incidence rises sharply after age 60. In the United Kingdom, the incidence is about 60 per 100,000 adults per year, and the mortality rate ranges from 2% to 8% depending on the cause and the speed of treatment NICE (2023).

Symptoms

Signs and symptoms may vary from subtle to life‑threatening. Common manifestations include:

• Hematemesis – vomiting of fresh blood (bright red) or “coffee‑ground” material (old blood).
• Melena – black, tarry stools indicating digested blood; may be preceded by bright red blood per rectum if the bleed is brisk.
• Hematochezia – bright red blood per rectum; usually signals a rapid bleed that passes through the colon unchanged.
• Upper abdominal pain or discomfort – often described as gnawing or burning.
• Sudden weakness, dizziness, or fainting (syncope) – due to acute blood loss and resultant drop in blood pressure.
• Shortness of breath or rapid heart rate (tachycardia) as the body compensates for reduced circulating volume.
• Feeling of fullness or nausea – especially after a bleed has begun.
• Fatigue or pallor – signs of chronic or recurrent blood loss.
• Swelling of the abdomen (distension) – can occur with massive bleeding and underlying ulcer disease.

Causes and Risk Factors

Common Causes

• Peptic ulcer disease (PUD) – the leading cause (≈50% of cases). Ulcers erode into submucosal vessels.
• Gastric erosions or gastritis – especially related to NSAID use or alcohol.
• Esophageal varices – dilated veins in cirrhosis; bleed massively when ruptured.
• Mallory‑Weiss tear – mucosal laceration at the gastro‑esophageal junction after forceful vomiting.
• Gastric cancer or duodenal tumors – can invade blood vessels.
• Dieulafoy’s lesion – an abnormal, large submucosal artery that erodes the overlying mucosa.
• Angiodysplasia – ectatic vessels in the stomach or duodenum.

Risk Factors

• Chronic use of non‑steroidal anti‑inflammatory drugs (NSAIDs) or aspirin.
• Heavy alcohol consumption (>3 drinks/day).
• Infection with Helicobacter pylori, the main driver of peptic ulcers.
• Advanced liver disease (cirrhosis) leading to portal hypertension.
• Severe stress (e.g., major surgery, burns, traumatic brain injury) – “stress‑related erosive disease”.
• Coagulopathy or anticoagulant therapy (warfarin, DOACs, heparin).
• Smoking – impairs mucosal protection.
• Older age (>60 years) – decreased mucosal defense and higher prevalence of comorbidities.

Diagnosis

Prompt recognition and evaluation are essential. The diagnostic work‑up typically follows a stepwise approach:

Initial Assessment

• Vital signs and hemodynamic status – blood pressure, heart rate, oxygen saturation.
• Physical examination focusing on abdomen, signs of chronic liver disease, and rectal exam for melena.
• Laboratory tests: CBC (hemoglobin/hematocrit), coagulation profile (PT/INR, aPTT), serum electrolytes, blood urea nitrogen (BUN) – an elevated BUN/creatinine ratio may suggest an upper GI source.

Endoscopic Evaluation

Upper endoscopy (esophagogastroduodenoscopy, EGD) is the gold standard. Performed within 24 hours of presentation, it allows:

• Direct visualization of the bleeding site.
• Therapeutic intervention (see Treatment section).
• Biopsy of suspicious lesions.

Imaging & Adjunct Tests

• CT angiography – useful when endoscopy is unavailable or non‑diagnostic; can localize active extravasation.
• Radionuclide (99mTc‑labeled) scan – detects low‑rate bleeding (<0.5 mL/min).
• Angiography – both diagnostic and therapeutic (embolization) for massive or refractory bleeding.
• Nasogastric tube lavage – may help confirm the presence of blood in the stomach, though its routine use is debated.

Treatment Options

Treatment aims to stabilize the patient, stop the bleeding, and address the underlying cause.

Resuscitation & Initial Management

• Secure airway if vomiting blood compromises breathing.
• Two large‑bore IV lines; give isotonic crystalloid (e.g., normal saline) bolus, then consider blood transfusion if hemoglobin <7 g/dL (or higher threshold in cardiovascular disease).
• Correct coagulopathy: vitamin K, fresh frozen plasma, or prothrombin complex concentrates as indicated.
• Intravenous proton‑pump inhibitor (PPI) infusion (e.g., 80 mg bolus then 8 mg/hr) to reduce acid and stabilize clots.

Endoscopic Therapy

Performed during EGD, techniques include:

• Injectable agents – epinephrine (1:10,000) to induce vasoconstriction.
• Thermal coagulation – heater probe, bipolar cautery.
• Mechanical clips – hemoclips placed directly on visible vessels.
• Band ligation – first‑line for esophageal varices.

Pharmacologic Therapy

• High‑dose IV PPIs for 72 hours (e.g., omeprazole, pantoprazole) even after successful endoscopic hemostasis.
• For variceal bleeding, octreotide (somatostatin analog) or terlipressin** reduces portal pressure.
• Antibiotic prophylaxis (e.g., ceftriaxone) in cirrhotic patients with variceal bleed to prevent spontaneous bacterial peritonitis.

Radiologic & Surgical Interventions

• Trans‑arterial embolization (TAE) – selectively occludes bleeding artery when endoscopy fails.
• Emergency surgery – partial gastrectomy, duodenal resection, or oversewing of bleeding ulcer; reserved for uncontrolled hemorrhage or perforation.

Long‑Term Medical Management

• Eradication of H. pylori with triple therapy (clarithromycin‑based) or quadruple regimens.
• Discontinuation or substitution of NSAIDs; consider COX‑2 selective inhibitors** with gastro‑protective agents if NSAIDs are essential.
• Maintenance PPI therapy for high‑risk ulcer patients (e.g., prior bleed, anticoagulation).

Living with Upper Gastrointestinal Bleed

Medication Management

• Take prescribed PPIs exactly as directed; avoid missing doses.
• If on anticoagulants, coordinate with your physician for dose adjustments or temporary cessation during acute episodes.

Dietary Guidance

• Start with a bland, low‑acid diet (e.g., bananas, rice, applesauce, toast – the “BRAT” diet) after an acute bleed.
• Gradually re‑introduce fiber‑rich foods, lean proteins, and non‑citrus fruits.
• Avoid alcohol, caffeine, spicy foods, and carbonated drinks until healing is confirmed.

Lifestyle & Monitoring

• Stop smoking – nicotine impairs mucosal blood flow.
• Maintain a healthy weight; obesity is linked to GERD, which can worsen ulcer disease.
• Track symptoms daily (e.g., any black stools or “coffee‑ground” vomit) and keep a log for your clinician.
• Schedule follow‑up endoscopy as advised (usually 4–8 weeks after a treated ulcer bleed).

Prevention

• Screen for and eradicate H. pylori in patients with dyspepsia or a history of ulcer disease.
• Use the lowest effective dose of NSAIDs; co‑prescribe a PPI or misoprostol when NSAIDs are unavoidable.
• Limit alcohol intake to ≤1 drink/day for women and ≤2 drinks/day for men.
• Control liver disease progression: abstain from alcohol, manage hepatitis, and maintain vaccination status (HBV, HAV).
• For patients on anticoagulants, regular INR monitoring (warfarin) or renal function checks (DOACs) to prevent over‑anticoagulation.
• Adopt a balanced diet rich in fruits, vegetables, and whole grains to reinforce mucosal health.

Complications

If left untreated or inadequately managed, UGIB can lead to serious sequelae:

• Hypovolemic shock – life‑threatening drop in blood pressure and organ perfusion.
• Acute kidney injury due to reduced renal perfusion.
• Respiratory failure from aspiration of blood.
• Transient or permanent anemia requiring chronic transfusion.
• Perforated ulcer – free air in abdomen, peritonitis, and need for urgent surgery.
• Re‑bleeding – occurs in 10–30% of patients within 7–14 days, especially if risk factors persist.
• Long‑term mortality risk increases with age, comorbid heart or lung disease, and ongoing alcohol misuse.

When to Seek Emergency Care

---

References (accessed May 2026):

1. Mayo Clinic. “Upper gastrointestinal bleeding.” https://www.mayoclinic.org
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Peptic Ulcer.” https://www.niddk.nih.gov
3. American College of Gastroenterology. “Management of Upper GI Bleeding.” Gastroenterology 2022; 163(2): 467‑485.
4. World Health Organization. “Guidelines for the Management of Severe Acute Malnutrition.” 2021.
5. National Institute for Health and Care Excellence (NICE). “Upper GI bleeding: diagnosis and management.” NG158, 2023.
6. Cleveland Clinic. “Esophageal Varices.” https://my.clevelandclinic.org
7. Huang J, et al. “Epidemiology of upper gastrointestinal bleeding in the United States.” J Gastroenterol Hepatol. 2021;36(5):1150‑1157.

```